F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Active Fund

Overlap Holdings

overlapholdings.com · New York, NY

“Refocus venture capital on solving world-scale problems by bridging the financing gap for frontier tech companies at the intersection of scientific innovation and hardware, combining equity investment with free debt and government-funding advisory services.”

Follows
Lead Tendency
$33M
AUM
01Investment Thesis

Refocus venture capital on solving world-scale problems by bridging the financing gap for frontier tech companies at the intersection of scientific innovation and hardware, combining equity investment with free debt and government-funding advisory services.

Exclusion Criteria

Avoids pure software investments, viewing the category as overcrowded, undifferentiated, and increasingly risky relative to hardware and frontier tech.

02Investment Team
JS
Justin Stevens
Founder + CEO
GJ
Gauri Jaswal
Principal
JA
John Ahrens
Senior Associate
RM
Rob Morelli
Chief Operating Officer / Managing Director of Capital Solutions
ES
Elizabeth Stockton
Director of Government Solutions
IE
Irene Edwards
Chief Communications Officer / Head of Investor Relations
03F4 Research Brief

Overlap Holdings Research

Investment Thesis

Overlap Holdings is a New York-based venture capital firm founded in 2022 by Justin Stevens, a former 18-year Senior Partner at Apollo Global Management. The firm brands itself as bringing "Wall Street meets Silicon Valley" to frontier tech investing: it pairs early-stage equity checks with an in-house financial-structuring practice that helps capital-intensive startups navigate debt and non-dilutive government funding. The stated mission is to "refocus venture capital on solving world-scale problems" by fixing the financing gap that keeps capital away from hardware-intensive frontier tech in favor of software.

Overlap operates three integrated business lines: (1) Investing — equity checks into Seed through Series B rounds; (2) Capital Solutions — debt/lender matchmaking services, drawing on 30+ years of financial-structuring expertise and a network of 250+ lender relationships, offered free to portfolio companies; and (3) Government Solutions — advisory on non-dilutive government funding (grants, defense contracts, DoD relationships), also free to portfolio companies. The firm explicitly does not lead equity rounds, instead following well-regarded co-investors while differentiating on this financing value-add.

Sector Focus

Overlap invests exclusively in "frontier tech" — companies building at the intersection of scientific innovation and hardware. Publicly stated focus sectors are Energy, Life Science, Materials Science, Space, Robotics, and Semiconductors. The firm is explicitly skeptical of pure software investing; founder Justin Stevens has written publicly (Crunchbase News) arguing pure software has become overcrowded and undifferentiated relative to hardware/frontier tech.

Stage Focus

Overlap invests in Seed, Series A, and Series B equity rounds ("early-stage, Seed through Series B" per its own materials). It does not do pre-seed or growth-stage equity as a matter of stated strategy.

Check Size

The firm's debut fund, Overlap Holdings Flagship Fund 1 (OHF1), closed at $33 million in February 2025. Per the firm's own announcement, it targets 30–35 total investments out of that fund at an average check of roughly $700,000.

Lead Tendency

Overlap does not lead rounds. Per its About page: "We do not lead rounds, but prefer to follow great VCs while providing a differentiated value-add" — namely, the free Capital Solutions and Government Solutions financing help.

Recent Activity

OHF1 held its final close in February 2025 at $33 million, and the firm has stated it is actively deploying toward its 30–35 investment target. As of this research, the publicly listed portfolio includes 17 named companies plus two disclosed stealth investments. Notable recent portfolio activity includes portfolio company Tahoe Therapeutics (formerly Vevo Therapeutics) raising a $30 million round in August 2025 to build AI models of human cells for drug discovery.

Portfolio Highlights

Overlap's portfolio spans its target sectors: Impulse Space and Starfish Space (space logistics/mobility), Muon Space (satellites), Hadrian and Foundation Alloy (advanced manufacturing/materials), Aerones (robotics), Efficient Computer (low-power silicon/compute), Anthro Energy and Antora (energy/thermal storage), XFuel (energy), Glacier (waste/recycling robotics, backed alongside NEA and EIF), Integrated Biosciences and Ridge Biotechnologies (life sciences), Mendaera (medical robotics), Lydian (life sciences), SiPhox Health (diagnostics, a Y Combinator alum backed alongside Khosla Ventures and Intel Capital), and Tahoe Therapeutics (AI-driven drug discovery). No exits have been publicly disclosed to date, consistent with the firm's young age (founded 2022, fund closed 2025).

Team

  • Justin Stevens, Founder + CEO — 18+ years as a Senior Partner at Apollo Global Management; deep financial-structuring and investment-management background across early-stage frontier tech through large public companies.
  • Gauri Jaswal, Principal — Focuses on Investing and Capital Solutions. First hire at Conscience VC (helped build sourcing/investment process); previously at dlab (an SOSV accelerator) and Outlier Ventures. Economics degree, Yale University.
  • John Ahrens, Senior Associate — Focuses on Investing and Capital Solutions. Background spans mechanical engineering, materials science, and cardiovascular tissue engineering; previously Co-Founder/CEO of biomanufacturing startup Reel Bio. B.S. Biomechanical Engineering (Stanford), Ph.D. Bioengineering (Harvard).
  • Rob Morelli, Chief Operating Officer / Managing Director of Capital Solutions — Began career at UBS Investment Bank, rising to Head of Syndicate and Structuring for Mortgage and Asset-Backed Structured Products. Co-founded HomeKeepr (acquired 2021). Registered Representative of BA Securities, LLC. Cornell University.
  • Elizabeth Stockton, Director of Government Solutions — Former Department of Defense official; handled homeland defense and emerging-technology policy for the Under Secretary of Defense for Policy, and served as Chief of Staff to the first Assistant Secretary of Defense for Industrial Base Policy ($2B/year in industrial base investments). International Relations degree, University of St Andrews.
  • Irene Edwards, Chief Communications Officer / Head of Investor Relations — 20 years in legacy media (Condé Nast, Time Inc., American Express Publishing); most recently Head of Communications at MAD (Copenhagen-based food-systems nonprofit). Medill School of Journalism, Northwestern University.

Decision Process

Overlap runs a small dedicated Investing Team (Stevens, Jaswal, Ahrens) alongside COO Rob Morelli, functioning as a partnership rather than a single decision-maker; sourcing and diligence draw on a network of technical experts across the firm's focus industries.

Founder Preferences

While not explicitly stated, Overlap's portfolio and thesis point toward technical founders building hardware-intensive, IP-defensible businesses in capital-intensive sectors — the opposite of the "two college kids and an app" software risk profile the firm has publicly criticized.

Geographic Focus

Headquartered in New York City. Publicly listed portfolio companies are overwhelmingly US-based (California, and other US frontier-tech hubs); no explicit international geographic focus is stated.

Notable Signals

Overlap has generated above-average press for a firm of its size and age: The Wall Street Journal profiled its debt-advisory/venture hybrid model at fund launch; Fortune's Term Sheet newsletter featured founder Justin Stevens on founder-control and governance trends; Business Insider covered the launch of the firm's Government Solutions business and the hire of Elizabeth Stockton to lead it; and both Stevens and Morelli have contributed bylined opinion pieces to Crunchbase News.

04Selected Portfolio
Aerospace & Defense
Impulse Space·Muon Space·Starfish Space
Biotech & Life Sciences
Tahoe Therapeutics·Integrated Biosciences·Ridge Biotechnologies
Climate & Sustainability
Xfuel·Lydian
Energy & Power
Anthro Energy·Antora
Healthcare & Digital Health
Mendaera·SIPhox
Manufacturing & Industrial
Foundation Alloy·hadrian.co
Robotics & Automation
Aerones·Glacier
Other
Efficient Computer
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (8) →
COO Rob Morelli published a bylined essay on Crunchbase News with advice for founders seeking debt financing.
ESSAY·news.crunchbase.com
Added recently
Justin Stevens published a bylined essay on Crunchbase News arguing pure software investing has become overcrowded and riskier than frontier tech.
ESSAY·news.crunchbase.com
Added recently
Portfolio company Tahoe Therapeutics (formerly Vevo Therapeutics) raised $30M to build AI models of human cells for drug discovery.
MILESTONE·tahoebio.ai
AUG 11, 2025
Founder Justin Stevens discussed space-sector financing strategy on the Space Business podcast.
PODCAST·spacebusiness.podbean.com
JUN 2025
Founder Justin Stevens featured in Fortune's Term Sheet newsletter discussing founder control and governance trends in venture deals.
PRESS·fortune.com
MAY 2, 2025
06Frequent co-investors
US
Union Square Ventures
Both backed 3 of the same companies
Anthro Energy, Xfuel, Lydian
OV
Overture VC
Both backed 2 of the same companies
Glacier, Lydian
SV
Silent Ventures
Both backed 2 of the same companies
Impulse Space, Starfish Space
SC
Space Capital
Both backed 2 of the same companies
Muon Space, Impulse Space
TV
Trousdale Ventures
Both backed 2 of the same companies
Impulse Space, Starfish Space
Find the investors for your round→
07Similar Firms
C
Cantos
$400K – $1.5M · Pre-Seed · Seed
→
AV
Aera VC
$500K – $20M · Pre-Seed · Seed
→
FS
Fine Structure Ventures
Pre-Seed · Seed
→
CV
Crosscut Ventures
$500K – $10M · Seed · Series A
→
AV
Asymmetry Ventures
$100K – $500K · Seed · Pre-Seed
→
Quick Reference
Stages
Seed · Series A · Series B
AUM
$33M
Decision
Partnership
Involvement
Advisor
Location
New York, NY
Sector Focus
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationEnergy & Power
Technology
HardwareFrontier TechDeep Tech
See all Manufacturing & Industrial investors →See all Aerospace & Defense investors →See all Biotech & Life Sciences investors →
Visit overlapholdings.com ↗

See how Overlap Holdings matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Manufacturing & IndustrialAerospace & DefenseBiotech & Life SciencesSemiconductors & HardwareRobotics & AutomationEnergy & Power

See how Overlap Holdings matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched September 25, 2026F4 Research Engine